Sarepta Therapeutics’ Diane Berry in a recent Patients Rising Podcast discussed access to treatments for rare diseases.
Berry is Sarepta Therapeutics’ senior vice president of global health policy.
“Patients with rare diseases may soon have better access to treatments,” a description of the podcast states. “A second installment to the 21st Century Cures Act is in the works that would make improvements to telemedicine and digital health regulations.”
To listen to the podcast, click here.